EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of "Buy" from Analysts wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Passes Above Two Hundred Day Moving Average of $17.27 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) SVP Sells $22,500.00 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) SVP David Scott Jones sold 600 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $25.00, for a total value of $15,000.00. Following the completion of the sale, the senior vice president now […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) shares rose 5.1% during mid-day trading on Wednesday . The company traded as high as $21.35 and last traded at $21.01. 560,366 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 791,399 shares. The stock had previously closed at $20.00. […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) major shareholder Ew Healthcare Partners, L.P. sold 60,858 shares of the stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $11.71, for a total transaction of $712,647.18. Following the completion of the sale, the insider now owns 3,738,246 shares […]
EyePoint Pharmaceuticals (NASDAQ: EYPT) has recently received a number of price target changes and ratings updates: 8/11/2023 – EyePoint Pharmaceuticals was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 8/3/2023 – EyePoint Pharmaceuticals was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating. 8/3/2023 – EyePoint […]
EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($1.02), reports. EyePoint Pharmaceuticals had a negative net margin of 283.81% and a negative return on equity of 82.21%. The company had revenue […]